Today on Outsourcing-Pharma.com   Merck inks multi-million dollar deal with Cognizant Chao Centre gets rights to manufacture TB drug MDS Pharma continues efforts to move on from FDA review Preclinical services news in brief Excipient market set to change, says report

Related Industry News   Pfizer buys CovX to bulk biologics pipeline NIH cash for new tools to unravel genome's secrets Semen fibrils ferry HIV into cells Biogen Idec shares nosedive after withdrawing 'for sale' sign

Breaking News on Outsourcing Pharma
Daily  Wednesday 19 December 2007		Forward to a colleague

	Sponsored Link Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here Access Full Stories Merck inks multi-million dollar deal with Cognizant Merck & Co. has just inked "multi-million dollar" deal with Cognizant, at a time when the US-based IT services firm is pursuing a greater presence in the life sciences sector... Read Chao Centre gets rights to manufacture TB drug Eli Lilly has handed over the manufacturing reins of the antibiotic Seromycin to the Chao Centre for Industrial Pharmacy and Contract Manufacturing... Read MDS Pharma continues efforts to move on from FDA review MDS Pharma is continuing its efforts to move on from the trouble caused in its Pharma Services segment by a US Food and Drug Administration (FDA) review of its Montreal-area bioanalytical facilities... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving Ocimum Biosolutions, ChemDiv and MIR Preclinical Services... Read Excipient market set to change, says report Advances in the pharmaceutical industry are expected to have an impact on pharmaceutical excipients within the next decade, a new report claims... Read
	All News Headlines for: December | November | October
	Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here
	Related Industry News Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read NIH cash for new tools to unravel genome's secrets The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse... Read Semen fibrils ferry HIV into cells Tiny protein fibres in semen have been found to enhance the ability of HIV to infect cells by up to 100,000 fold and could provide drug developers with a potent new target to tackle the virus... Read Biogen Idec shares nosedive after withdrawing 'for sale' sign Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Previous Headlines William Ransom & Son's future profitability questionable UK-based William Ransom & Son has a shaky future ahead following a disappointing and unacceptable six-month financial report, compounded by a suspension of the companys manufacturing license... Read French CROs have eye on niche market Two French contract research organisations (CROs) that specialise in ophthalmology have banded together to offer specialised services to this niche market... Read Siegfried and Arena sign contract manufacturing deal Siegfried has signed a $27.7m contract with Arena Pharmaceuticals to manufacture Arena's Phase III oral obesity drug candidate lorcaserin hydrochloride... Read Pharmaceutical contract services round-up In a round-up of motley pharmaceutical services contracts, Outsourcing-Pharma takes a look at recent news involving United Drug, Movianto and IBM... Read Oxford Genome Sciences advances on Amgen deal Oxford Genome Sciences (OGeS) has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com